Which technology underpins the ME panel results?

Which technology underpins the ME panel results?

• A. Mass spectrometry
• B. Fluorescent In Situ Hybridization
• C. Nanoparticle probe technology
• D. MALDI-TOF

Answer: (C)

Nanoparticle probe technology underpins ME panel results, enabling rapid, multiplex detection of multiple targets in a single assay. Probes attached to nanoparticles bind to specific nucleic acid sequences from the pathogens of interest, and this binding generates a measurable signal that the instrument reads for each target. This approach provides high sensitivity and a closed, rapid workflow, which is ideal for syndromic panels like the ME panel. Other detection methods operate differently: mass spectrometry-based identification (as used by MALDI-TOF) relies on analyzing mass spectra from cultured organisms, while fluorescence in situ hybridization requires microscopic visualization of labeled probes in samples. Those methods are not how the ME panel delivers its results, making nanoparticle probe technology the correct underpinning mechanism.

Nanoparticle probe technology underpins ME panel results, enabling rapid, multiplex detection of multiple targets in a single assay. Probes attached to nanoparticles bind to specific nucleic acid sequences from the pathogens of interest, and this binding generates a measurable signal that the instrument reads for each target. This approach provides high sensitivity and a closed, rapid workflow, which is ideal for syndromic panels like the ME panel. Other detection methods operate differently: mass spectrometry-based identification (as used by MALDI-TOF) relies on analyzing mass spectra from cultured organisms, while fluorescence in situ hybridization requires microscopic visualization of labeled probes in samples. Those methods are not how the ME panel delivers its results, making nanoparticle probe technology the correct underpinning mechanism.